Rathbones Group PLC Has $18.57 Million Holdings in HCA Healthcare, Inc. $HCA

Key Points

• Rathbones Group PLC reduced its stake in HCA by 12.2% in Q4, selling 5,532 shares and now holds 39,771 shares valued at about $18.57 million.
• Insiders sold 15,214 shares worth roughly $7.8 million last quarter — including SVP Jennifer Berres selling 8,020 shares at an average $514.58 — and insiders now own 1.50% of the company.
• Wall Street is broadly positive (16 Buys, 8 Holds, 1 Sell) with an average price target of $537.73; HCA raised FY2026 EPS guidance to $29.10–$31.50 and boosted its quarterly dividend to $0.78 ($3.12 annualized).

Rathbones Group PLC lowered its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 12.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 39,771 shares of the company's stock after selling 5,532 shares during the quarter. Rathbones Group PLC's holdings in HCA Healthcare were worth $18,567,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in the business. Capital World Investors increased its position in HCA Healthcare by 3.8% in the 3rd quarter. Capital World Investors now owns 4,959,336 shares of the company's stock worth $2,113,662,000 after purchasing an additional 179,443 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its holdings in shares of HCA Healthcare by 1.8% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 2,065,225 shares of the company's stock valued at $880,199,000 after acquiring an additional 36,414 shares during the last quarter. Viking Global Investors LP increased its holdings in shares of HCA Healthcare by 58.5% during the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company's stock valued at $717,214,000 after acquiring an additional 690,773 shares during the last quarter. Legal & General Group Plc grew its position in shares of HCA Healthcare by 0.8% in the third quarter. Legal & General Group Plc now owns 1,124,511 shares of the company's stock valued at $479,267,000 after purchasing an additional 8,478 shares during the last quarter. Finally, Invesco Ltd. grew its position in shares of HCA Healthcare by 1.1% in the third quarter. Invesco Ltd. now owns 1,100,929 shares of the company's stock valued at $469,216,000 after purchasing an additional 11,829 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.

Insider Buying and Selling at HCA Healthcare

In other news, SVP Jennifer Berres sold 8,020 shares of the firm's stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the completion of the transaction, the senior vice president directly owned 11,993 shares of the company's stock, valued at $6,171,357.94. This trade represents a 40.07% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Michael S. Cuffe sold 1,500 shares of the stock in a transaction that occurred on Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total value of $747,135.00. Following the transaction, the executive vice president directly owned 30,003 shares of the company's stock, valued at $14,944,194.27. This trade represents a 4.76% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 15,214 shares of company stock valued at $7,797,595 over the last quarter. Insiders own 1.50% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on HCA shares. Jefferies Financial Group raised their price target on shares of HCA Healthcare from $535.00 to $590.00 and gave the stock a "buy" rating in a research report on Wednesday, January 28th. Mizuho boosted their price target on HCA Healthcare from $540.00 to $585.00 and gave the company an "outperform" rating in a research note on Wednesday, February 25th. Truist Financial lifted their target price on shares of HCA Healthcare from $520.00 to $546.00 and gave the company a "buy" rating in a research note on Wednesday, January 28th. Wall Street Zen cut shares of HCA Healthcare from a "strong-buy" rating to a "buy" rating in a research note on Saturday, February 14th. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on shares of HCA Healthcare from $500.00 to $558.00 and gave the stock a "buy" rating in a research note on Wednesday, January 28th. Sixteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $537.73.

HCA Healthcare Stock Up 2.5%

HCA opened at $483.41 on Tuesday. HCA Healthcare, Inc. has a 12 month low of $314.43 and a 12 month high of $556.52. The company has a fifty day simple moving average of $511.38 and a 200 day simple moving average of $479.59. The stock has a market cap of $108.08 billion, a P/E ratio of 17.03, a P/E/G ratio of 1.45 and a beta of 1.36.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, beating analysts' consensus estimates of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The business had revenue of $19.51 billion during the quarter, compared to analysts' expectations of $19.67 billion. During the same quarter in the prior year, the company earned $6.22 EPS. The firm's quarterly revenue was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th were given a dividend of $0.78 per share. This is an increase from HCA Healthcare's previous quarterly dividend of $0.72. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend was Tuesday, March 17th. HCA Healthcare's payout ratio is currently 10.99%.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.